| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2019 | 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin | Ming-Shiu Lin; Tse-Ming Hong; Ting-Hung Chou; Shuenn-Chen Yang; Wei-Chia Chung; Chia-Wei Weng; Mei-Ling Tsai; Ting-Jen Rachel Cheng ; Jeremy J. W. Chen; Te-Chang Lee ; Chi-Huey Wong ; Rong-Jie Chein ; Pan-Chyr Yang | European Journal of Medicinal Chemistry 181, 111584 | | | |
| 2020 | Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells | Hu, Wei-Chun; Teo, Wan-Huai; Huang, Tung-Fu; Lee, Te-Chang ; Lo, Jeng-Fan | Frontiers in Oncology 10, 463 | | | |
| 2019 | Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1- a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links. | Chang, SM; Jain, V; Chen, TL; Patel, AS; Pidugu, HB; Lin, YW; Wu, MH; Huang, JR; Wu, HC; Shah, A; Su, TL; Lee, TC | Journal of medicinal chemistry 62(5), 2404-2418 | | | |
| 2020 | Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives | Patel, Anilkumar S.; Jain, Vicky; Rao, Vaikar Navakanth; Lin, Yi-Wen; Shah, Anamik; Lai, Kuo-Chu; Su, Tsann-Long; Lee, Te-Chang | European Journal of Medicinal Chemistry 202, 112516 | | | |
| 2021 | Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links | Chen, TL; Patel, AS; Jain, V; Kuppusamy, R; Lin, YW; Hou, MH; Su, TL; Lee, TC | Journal of Medicinal Chemistry 64(17), 12469-12486 | | | |
| 2016 | Effect of heme oxygenase-1 gene promoter polymorphism on cancer risk by histological subtype: A prospective study in arseniasis-endemic areas in Taiwan. | Wu, MM; Lee, CH; Hsu, LI; Cheng, WF; Lee, TC ; Wang, YH; Chiou, HY; Chen, CJ | International journal of cancer 138(8), 1875-86 | | | |
| 2019 | Emerging functions of human IFIT proteins in cancer | Pidugu, VK; Pidugu, HB; Wu, MM; Liu, CJ; Lee, TC | Frontiers in Molecular Biosciences-Molecular Diagnostics and Therapeutics 6, 148 | | | |
| 2021 | Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese | Wei, CY; Yang, JH; Yeh, EC; Tsai, MF; Kao, HJ; Lo, CZ; Chang, LP; Lin, WJ; Hsieh, FJ; Belsare, S; Bhaskar, A; Su, MW; Lee, TC ; Lin, YL ; Liu, FT ; Shen, CY ; Li, LH ; Chen, CH ; Wall, JD; Wu, JY ; Kwok, PY | NPJ Genomic Medicine 6(1), 10 | | | |
| 2021 | GT-repeat polymorphism in the HO-1 gene promoter is associated with risk of liver cancer: A follow-up study from arseniasis-endemic areas in Taiwan | Wu, MM; Hsieh, FI; Hsu, LI; Lee, TC ; Chiou, HY; Chen, CJ | Journal of Clinical Medicine 10(7), 1489 | | | |
| 2019 | IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling. | Pidugu, VK; Wu, MM; Yen, AH; Pidugu, HB; Chang, KW; Liu, CJ; Lee, TC | Oncogene 38(17), 3232-3247 | | | |
| 2020 | SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells | Regmi, Prabha; Lai, Kuo-Chu; Liu, Chung-Ji; Lee, Te-Chang | Cancers 12(12), 3527 | | | |
